Table 2 Mutations associated with failure to achieve EFS24

From: Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma

Gene

Overall number of patients with mutation

Patients achieving EFS24 (N=38)

Failure to achieve EFS24 (N=13)

P-value

Cytogenetic band

In region of CNA

Human genome compendium description

GO annotation/function

  

N with mutation

% With mutation

N with mutation

% With mutation

     

ODZ3/TENM3

4

0

0

4

31

0.003

5q34

Yes

Tenascin family

Protein heterodimerization and homodimerization activity

KIAA1614

5

1

2.6

4

31

0.02

1q25.3

Yes

Reported gene with no known function

C10orf12

3

0

0

3

23

0.02

10q24.1

Yes

Reported gene with no known function

DIAPH2

3

0

0

3

23

0.02

Xq21.33

No

Formin homology family

Rho GTPase binding and actin binding

SEC14L5

3

0

0

3

23

0.02

16p13.3

Yes

Reported gene with no known function

BAI1

3

0

0

3

23

0.02

8q24.3

Yes

G-protein-coupled receptor

G-protein-coupled receptor activity

SDK2

3

0

0

3

23

0.02

17q25.1

Yes

Immunoglobulin superfamily

Cell adhesion

TRIM2

3

0

0

3

23

0.02

4q31.1

Yes

Tripartitie motif family

Ubiquitin-protein ligase activity and zinc ion binding

MYO19

3

0

0

3

23

0.02

17q12

Yes

Myosin

Motor activity and actin binding

FBLN2

3

0

0

3

23

0.02

3p25.1

Yes

Fibulin family

Extracellular matrix binding and calcium ion binding

COL12A1

3

0

0

3

23

0.02

6q13

Yes

Alpha chain of type XII collagen

Stuctural molecule activity

ALDH3A2

3

0

0

3

23

0.02

17p11.2

Yes

Aldehyde dehydrogenase family

Long-chain-alcohol oxidase and aldehyde dehydrogenase (NAD)

KIF1C

3

0

0

3

23

0.02

17p13.2

Yes

Kinesin family

Motor activity and microtubule motor activity

HEPH

3

0

0

3

23

0.02

11q12

No

Multicopper oxidase protein family

Oxidoreductase activity and copper ion binding

FGFRL1

3

0

0

3

23

0.02

4p16

Yes

Fibroblast growth factor receptor

Heparin binding and fibroblast growth factor-activated receptor activity

HERC2

8

3

7.9

5

38

0.03

15q13

Yes

HERC gene family

Ubiquitin-protein ligase activity and heme binding

  1. Abbreviations: CNA, copy number alteration; EFS24, event-free survival at 24 months after diagnosis; GO, gene ontogeny.